Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyubo Kim

Showing results (131-140 of 240) with videos related to

Pageof 24
Sort By:
Plos One|September 1, 2022
Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancerTaeryool Koo, Kwang-Ho Cheong, Kyubo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2009
Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?Kyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
Japanese Journal of Clinical Oncology|December 9, 2008
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancerKyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
Protease-activated receptor 2-dependent fluid secretion from airway submucosal glands by house dust mite extractHyung-Ju Cho, Hyun Jae Lee, Sang Cheol Kim, et al.
American Journal of Clinical Oncology|June 11, 2011
Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experienceKyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
Plos One|September 19, 2015
Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant ChemotherapyTaeryool Koo, Changhoon Song, Jae-Sung Kim, et al.
Targeted Oncology|January 14, 2017
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant ChemoradiotherapyYu Jin Lim, Jaemoon Koh, Kyubo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Development and Validation of a Normal Tissue Complication Probability Model for Lymphedema After Radiation Therapy in Breast CancerYe-In Park, Jee Suk Chang, Heejoo Ko, et al.
Journal of Breast Cancer|June 30, 2020
Identifying Long-Term Survival Candidates among Patients with Isolated Locoregionally Recurrent Breast Cancer: Implications of the Use of Systemic ChemotherapyByoung Hyuck Kim, Kyung Hwan Shin, Eui Kyu Chie, et al.
Cancer Research and Treatment|December 28, 2018
Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant ChemoradiotherapyEunji Kim, Kyubo Kim, Se Hyung Kim, et al.
Pageof 24

Showing results (131-140 of 240) with videos related to

Sort By:
Pageof 24
Plos One|September 1, 2022
Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancerTaeryool Koo, Kwang-Ho Cheong, Kyubo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|December 8, 2009
Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?Kyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
Japanese Journal of Clinical Oncology|December 9, 2008
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancerKyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
The Journal of Allergy and Clinical Immunology|December 27, 2011
Protease-activated receptor 2-dependent fluid secretion from airway submucosal glands by house dust mite extractHyung-Ju Cho, Hyun Jae Lee, Sang Cheol Kim, et al.
American Journal of Clinical Oncology|June 11, 2011
Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experienceKyubo Kim, Eui Kyu Chie, Jin-Young Jang, et al.
Plos One|September 19, 2015
Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant ChemotherapyTaeryool Koo, Changhoon Song, Jae-Sung Kim, et al.
Targeted Oncology|January 14, 2017
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant ChemoradiotherapyYu Jin Lim, Jaemoon Koh, Kyubo Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Development and Validation of a Normal Tissue Complication Probability Model for Lymphedema After Radiation Therapy in Breast CancerYe-In Park, Jee Suk Chang, Heejoo Ko, et al.
Journal of Breast Cancer|June 30, 2020
Identifying Long-Term Survival Candidates among Patients with Isolated Locoregionally Recurrent Breast Cancer: Implications of the Use of Systemic ChemotherapyByoung Hyuck Kim, Kyung Hwan Shin, Eui Kyu Chie, et al.
Cancer Research and Treatment|December 28, 2018
Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant ChemoradiotherapyEunji Kim, Kyubo Kim, Se Hyung Kim, et al.
Pageof 24